These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37996195)

  • 1. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial - Authors' reply.
    Xie Y; Al-Aly Z
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):895-896. PubMed ID: 37996195
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
    Ceriello A; Prattichizzo F; Berra CC; Caballero AE
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):894-895. PubMed ID: 37996193
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
    Vural Keskinler M; Telci Caklili O; Oguz A
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):894. PubMed ID: 37996194
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
    Ahmed A; Anker SD; Butler J; Bakris GL; Bhatt DL; Fonarow GC; Packer M
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):892-894. PubMed ID: 37996192
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
    Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and oral agents for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2016 Apr; 4():CD004730. PubMed ID: 27087121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.
    Holman RR; Sourij H; Califf RM
    Lancet; 2014 Sep; 384(9948):1097-8. PubMed ID: 25241719
    [No Abstract]   [Full Text] [Related]  

  • 11. Choosing the correct metrics for glucose control. Authors' reply.
    Kaukonen KM; Bailey M; Pilcher D; Orford N; Bellomo R;
    Crit Care; 2014 Mar; 18(2):414. PubMed ID: 25180350
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
    Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Authors' reply.
    Chan PF; Lai LK; Wong SN; Chao DV; Lau IT
    Hong Kong Med J; 2013 Apr; 19(2):189. PubMed ID: 23535684
    [No Abstract]   [Full Text] [Related]  

  • 16. Interventions for prevention of neonatal hyperglycemia in very low birth weight infants.
    Sinclair JC; Bottino M; Cowett RM
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007615. PubMed ID: 21975772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for prevention of neonatal hyperglycemia in very low birth weight infants.
    Sinclair JC; Bottino M; Cowett RM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007615. PubMed ID: 19588439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design.
    Fulcher GR; Jarlov H; Piltoft JS; Singh KP; Liu L; Mohamed M; Nicodemus NA; Al-Jaser SJ; Kok A
    Endocrine; 2021 Dec; 74(3):530-537. PubMed ID: 34637072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "The pros and cons of continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin". Authors' reply.
    Petrizzo M; Maiorino MI; Esposito K
    Endocrine; 2018 Apr; 60(1):197. PubMed ID: 29404902
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial.
    Deng Y; Polley EC; Wallach JD; Herrin J; Ross JS; McCoy RG
    BMJ Med; 2023; 2(1):e000419. PubMed ID: 37577025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.